Do you want to read an article? Please log in or register.
Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study
COPDLung Cancer
Related content
RECOMMENDED
Lung Cancer
Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer
Lung Cancer.
Ilie M, Beaulande M, Hamila M, Erb G, Hofman V, Hofman P
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
COPD and lung cancer incidence in the Women's Health Initiative Observational Study: A brief report
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer.
Nagasaka M, Lehman A, Chlebowski R, Haynes BM, Ho G, Patel M, Sakoda LC, Schwartz AG, Simon MS, Cote ML
doi: 10.1016/j.lungcan.2020.01.006.
Lung Cancer
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score
Lung Cancer.
Balata H, Foden P, Edwards T, Chaturvedi A, Elshafi M, Tempowski A, Teng B, Whittemore P, Blyth KG, Kidd A, Ellames D, Flint LA, Robson J, Teh E, Jones R, Batchelor T, Crosbie P, Booton R, Evison M
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis
Lung Cancer.
Kort S, Tiggeloven MM, Brusse-Keizer M, Gerritsen JW, Schouwink JH, Citgez E, de Jongh FHC, Samii S, van der Maten J, van den Bogart M, van der Palen J
doi: 10.1016/j.lungcan.
COPDLung Cancer
Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer
Chest.
Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP
doi: 10.1016/j.chest.2018.01.049.
COMMENTED
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
Lancet Respir Med.
Duruisseaux M, Martínez-Cardús A, Calleja-Cervantes ME, Moran S, Castro de Moura M, Davalos V, Piñeyro D, Sanchez-Cespedes M, Girard N, Brevet M, Giroux-Leprieur E, Dumenil C, Pradotto M, Bironzo P, Capelletto E, Novello S, Cortot A, Copin MC, Karachaliou N, Gonzalez-Cao M, Peralta S, Montuenga LM, Gil-Bazo I, Baraibar I, Lozano MD, Varela M, Ruffinelli JC, Palmero R, Nadal E, Moran T, Perez L, Ramos I, Xiao Q, Fernandez AF, Fraga MF, Gut M, Gut I, Teixidó C, Vilariño N, Prat A, Reguart N, Benito A, Garrido P, Barragan I, Emile JF, Rosell R, Brambilla E, Esteller M
doi: 10.1016/S2213-
RECOMMENDED
Lung Cancer
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Tessema M, Tassew DD, Yingling CM, Do K, Picchi MA, Wu G, Petersen H, Randell S, Lin Y, Belinsky SA, Tesfaigzi Y
doi: 10.1016/j.lungcan.2020.05.017.
Lung Cancer
The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer
BMC Cancer.
Vanhove K, Giesen P, Owokotomo OE, Mesotten L, Louis E, Shkedy Z, Thomeer M, Adriaensens P
doi: 10.1186/s12885-018-4755-1.
RECOMMENDED
COPD
Predictive value of control of COPD for risk of exacerbations: An international, prospective study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1111/resp.13811.